Literature DB >> 685924

Plasma amino acids imbalance in patients with liver disease.

A Cascino, C Cangiano, V Calcaterra, F Rossi-Fanelli, L Capocaccia.   

Abstract

The venous plasma amino acid patterns have been determined in 12 normal individuals and in 71 shunted and nonshunted cirrhotics in various grades of hepatic encephalopathy. The free amino acids have been determined by an amino autoanalyzer; the total and free tryptophan have been measured by a spectrophotofluorimetric method. In 14 instances, arterial plasma amino acid patterns have been measured simultaneously. High levels of aromatic and sulfurated amino acids and low levels of branched-chain amino acids have been constantly found in all cirrhotics. Methionine, phenylalanine, valine, leucine, tyrosine, and free tryptophan showed a statistical difference between controls and all other groups. These altered patterns did not correlate either with the grade or the evolution of the coma or with the presence of the surgical anastomosis. No statistical differences were found between arterial and venous values. The only amino acid which statistically correlated with the grade and evolution of the hepatic encephalopathy was free tryptophan. The molar ratios between the amino acids sharing the same transport system across the blood-brain-barrier have been considered. A very good correlation with the grade of the mental disorder was found with the ratios free tryptophan/phenylalanine-tyrosine-methionine-valine-leucine-isoleucine and free tryptophan/branched-chain amino acids.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 685924     DOI: 10.1007/BF01072593

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  30 in total

1.  The plasma amino acids in patients with liver failure.

Authors:  F L IBER; H ROSEN; S M LEVENSON; T C CHALMERS
Journal:  J Lab Clin Med       Date:  1957-09

2.  Brain tryptophan, plasma free tryptophan and distribution of plasma neutral amino acids.

Authors:  J H James; J M Hodgman; J M Funovics; N Yoshimura; J E Fischer
Journal:  Metabolism       Date:  1976-04       Impact factor: 8.694

3.  Plasma free fatty acid in liver disease.

Authors:  A MORTIAUX; A M DAWSON
Journal:  Gut       Date:  1961-12       Impact factor: 23.059

4.  Regional brain study of indoleamine metabolism in the rat in acute hepatic failure.

Authors:  M G Cummings; J H James; P B Soeters; J M Keane; J Foster; J E Fischer
Journal:  J Neurochem       Date:  1976-09       Impact factor: 5.372

5.  Role of a false neurotransmitter, octopamine, in the pathogenesis of hepatic and renal encephalopathy.

Authors:  K C Lam; A R Tall; G B Goldstein; S P Mistilis
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

6.  False neurotransmitters and hepatic failure.

Authors:  J E Fischer; R J Baldessarini
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

Review 7.  Hepatic coma in cirrhosis, portal hypertension, and following portacaval shunt. Its etiologies and the current status of its treatment.

Authors:  J E Fischer
Journal:  Arch Surg       Date:  1974-03

8.  Urinary and serum octopamine in patients with portal-systemic encephalopathy.

Authors:  K K Manghani; M R Lunzer; B H Billing; S Sherlock
Journal:  Lancet       Date:  1975-11-15       Impact factor: 79.321

9.  Letter: Plasma neutral aminoacids and tryptophan in cirrhosis.

Authors:  H N Munro; J D Fernstrom; R J Wurtman
Journal:  Lancet       Date:  1975-08-30       Impact factor: 79.321

10.  Octopamine plasma levels and hepatic encephalopathy: a re-appraisal of the problem.

Authors:  F Rossi-Fanelli; C Cangiano; A Attili; M Angelico; A Cascino; L Capocaccia; R Strom; C Crifó
Journal:  Clin Chim Acta       Date:  1976-03-15       Impact factor: 3.786

View more
  15 in total

1.  Synergism between different transport systems stimulates the uptake of neutral amino acids by isolated brain microvessels.

Authors:  R Strom; P Cardelli; A Fiori; C Cangiano; D Barra; A Cascino; F Ceci; F Rossi-Fanelli
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

2.  Plasma amino acids in four models of experimental liver injury in rats.

Authors:  M Holeček; J Mráz; I Tilšer
Journal:  Amino Acids       Date:  1996-09       Impact factor: 3.520

Review 3.  Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part II. Clinical consequences and potential for pharmacological intervention in cirrhosis.

Authors:  E Pisi; G Marchesini
Journal:  Drugs       Date:  1990       Impact factor: 9.546

4.  Amino acids in hepatic coma.

Authors:  J E Fischer
Journal:  Dig Dis Sci       Date:  1982-02       Impact factor: 3.199

Review 5.  Progress in the treatment of chronic portasystemic encephalopathy.

Authors:  I R Crossley; R Williams
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

6.  Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy.

Authors:  A Cascino; C Cangiano; F Fiaccadori; F Ghinelli; M Merli; G Pelosi; O Riggio; F Rossi Fanelli; D Sacchini; M Stortoni; L Capocaccia
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

7.  Ammonia-induced changes in pancreatic hormones and plasma amino acids in patients with liver cirrhosis.

Authors:  G Marchesini; M Zoli; C Dondi; A Angiolini; A Melli; E Pisi
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

8.  Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalopathy.

Authors:  M L Zeneroli; G Pinelli; G Gollini; A Penne; E Messori; G Zani; E Ventura
Journal:  Gut       Date:  1984-03       Impact factor: 23.059

9.  Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis.

Authors:  Yoshiyuki Takahara; Mitsuo Takahashi; Hiroki Wagatsuma; Fumihiko Yokoya; Qing-Wei Zhang; Mutsuyo Yamaguchi; Hiroyuki Aburatani; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

Review 10.  Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences.

Authors:  F Rossi Fanelli; C Cangiano; L Capocaccia; A Cascino; F Ceci; M Muscaritoli; G Giunchi
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.